Dnib Unwind, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Dnib Unwind, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2006. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $150,000 in total, most recently in 2007. It has reported private securities offerings to the US SEC, most recently $8.7 million sold in a notice filed in 2013.
Dnib Unwind at a glance
What does Dnib Unwind do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $150,000 in total (2007).
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $8.7 million sold (2013).
Frequently asked questions about Dnib Unwind
Where is Dnib Unwind headquartered?
Dnib Unwind, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Dnib Unwind do?
Dnib Unwind, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Dnib Unwind founded?
The earliest incorporation on record for Dnib Unwind, Inc. is in 2006, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences